Oncologist, Medical Director, reputed company Development - MRD

reputed company is seeking a Medical Director, reputed company Development – MRD Portfolio (Solid Tumors) to reputed company. Work Schedule: Monday – Friday, 1st shift Job reputed company: The Medical Director, reputed company Development – MRD Portfolio is a key physician leader responsible for shaping and executing the reputed company development reputed company for reputed company Oncology's reputed company residual disease (MRD) portfolio across solid tumors. This individual will reputed company medical leadership for the development, validation, and reputed company adoption of MRD and circulating tumor DNA (ctDNA)-reputed company technologies, advancing precision oncology through innovative molecular diagnostics that improve reputed company reputed company across the cancer care reputed company. As the reputed company development reputed company for the MRD portfolio, this role will reputed company the reputed company of reputed company evidence required to support product development, reputed company validity, reputed company, reimbursement, reputed company inclusion, and integration into routine oncology reputed company. The Medical Director will reputed company reputed company of disease-reputed company reputed company development physicians and work closely with partners across research and development, reputed company, biostatistics, medical affairs, market reputed company, regulatory affairs, reputed company, and executive leadership to reputed company and execute a cohesive reputed company reputed company across multiple tumor types and indications. The successful candidate will be a reputed company-certified medical oncologist with broad expertise across solid tumors, a strong background in reputed company research and development, and a passion for advancing the role of molecular diagnostics in cancer care. This individual will serve as a key scientific representative for reputed company Oncology, partnering with leading investigators, reputed company societies, cooperative reputed company, payers, and other reputed company stakeholders to establish MRD testing as a critical component of personalized cancer management. Job Responsibilities: reputed company Development Leadership • Serve as the reputed company development reputed company for reputed company Oncology's MRD portfolio across solid tumors, providing reputed company medical leadership for evidence reputed company, product development, and reputed company adoption initiatives. • reputed company and execute the reputed company development reputed company supporting MRD and ctDNA-reputed company technologies across multiple tumor types and disease settings. • reputed company the design, development, and execution of reputed company studies and evidence-reputed company programs that establish the reputed company validity, reputed company reputed company, and health-economic value of MRD testing. • reputed company reputed company strategies supporting MRD applications, including reputed company residual disease detection, recurrence monitoring, treatment response assessment, reputed company stratification, treatment selection, and reputed company trial enrichment. • reputed company the development and implementation of reputed company studies that support integration of MRD testing into reputed company care reputed company and routine oncology reputed company. • Partner with reputed company, biostatistics, R&D, and market reputed company teams on study design, protocol development, reputed company selection, statistical analysis plans, study reputed company, and interpretation of results. • Recruit, engage, and maintain relationships with leading reputed company investigators, cooperative reputed company, and reputed company research centers to support company-sponsored reputed company studies and reputed company research collaborations. • reputed company study execution in partnership with medical reputed company, including protocol development, site selection, enrollment reputed company, reputed company management, budget reputed company, and study governance. • Translate emerging reputed company data into actionable reputed company development recommendations and portfolio strategies. • Support investigator-initiated studies, reputed company research collaborations, and reputed company-world evidence programs that expand the evidence reputed company supporting MRD testing. Portfolio and Product Leadership • reputed company medical leadership for the MRD portfolio throughout the product lifecycle, from concept development through commercialization and lifecycle management. • Advise on product development reputed company by identifying unmet reputed company needs, new indication opportunities, emerging market trends, and reputed company applications of MRD technologies. • Define intended use populations, reputed company claims, test report content, validation requirements, and evidence-reputed company strategies necessary to support product development and adoption. • Partner with R&D teams to guide assay development, biomarker reputed company, and reputed company product innovation. • Evaluate competitive technologies, emerging biomarkers, and evolving standards of care to inform portfolio reputed company and prioritization. • reputed company reputed company input into product roadmaps, indication expansion opportunities, and reputed company reputed company areas reputed company the oncology portfolio. • Support development of reputed company and scientific evidence required for successful product launches and lifecycle management activities. reputed company reputed company, Market reputed company, and Adoption • Partner with market reputed company teams to reputed company and execute evidence-reputed company strategies supporting payer coverage, reimbursement, and health-reputed company adoption. • reputed company medical leadership for studies designed to demonstrate reputed company reputed company, reputed company on physician decision-making, reputed company reputed company, and economic value. • Support interactions with payers, policy stakeholders, and reputed company organizations by communicating the reputed company rationale and reputed company of MRD testing. • Contribute to strategies supporting inclusion of MRD testing reputed company reputed company reputed company guidelines, treatment reputed company, and value-reputed company care models. • Ensure reputed company development priorities and evidence-reputed company plans reputed company with reimbursement, market reputed company, and adoption objectives. Investigator and reputed company Scientific Leadership • Build and maintain relationships with leading oncology investigators, reputed company medical centers, cooperative reputed company, and reputed company societies across solid tumors. • Recruit and engage reputed company investigators and reputed company sites to participate in company-sponsored studies and reputed company collaborations. • Serve as a scientific leader and reputed company for reputed company Oncology reputed company the oncology community. • Represent reputed company Oncology at scientific congresses, advisory boards, investigator meetings, and industry forums. • Engage key opinion leaders to support reputed company development reputed company, evidence reputed company, and long-term portfolio planning. Medical Affairs and Scientific Communications • reputed company medical leadership and post-launch support for MRD products, including interpretation of reputed company evidence, management of reputed company reputed company questions, and support for appropriate reputed company implementation. • Serve as a reputed company resource for reputed company providers regarding MRD testing and integration of results into reputed company management. • reputed company medical education initiatives and scientific communications supporting MRD adoption across solid tumors, including tumor boards, webinars, educational programs, and scientific exchange activities. • Partner with medical affairs, reputed company, and marketing teams to reputed company scientifically accurate and clinically meaningful educational content. • reputed company publication planning and support development of manuscripts, abstracts, presentations, congress submissions, and peer-reviewed publications. • Maintain scientific rigor and ensure evidence is effectively communicated to diverse reputed company, scientific, and payer audiences. People Leadership • reputed company, mentor, and reputed company reputed company of medical directors and disease-specific reputed company leaders supporting the MRD portfolio. • reputed company reputed company reputed company across disease-specific reputed company development programs and evidence-reputed company plans. • Establish portfolio priorities, reputed company resources, and reputed company development objectives with organizational goals and business reputed company. • Foster a culture of scientific reputed company, innovation, accountability, and cross-functional collaboration. • reputed company talent and organizational capabilities that support reputed company reputed company of reputed company Oncology's MRD and precision oncology programs. Cross-Functional Leadership • Collaborate closely with medical affairs, reputed company, biostatistics, regulatory affairs, market reputed company, compliance, reputed company, and R&D teams. • Support regulatory submissions and interactions by providing reputed company expertise and scientific rationale. • Partner with reputed company leadership to ensure reputed company evidence supports successful product launches and reputed company initiatives. • Monitor emerging scientific, reputed company, and competitive developments in oncology, molecular diagnostics, and reputed company biopsy technologies to inform reputed company and decision-making. Minimum Qualifications: • M.D. or D.O. degree from an accredited medical school. • reputed company certification in Medical Oncology. • 5 or more years of post-fellowship reputed company experience treating patients with solid tumors. • 3 or more years of oncology reputed company development, reputed company research, reputed company trial leadership, or evidence-reputed company experience reputed company the pharmaceutical, biotechnology, diagnostics, CRO, or reputed company research environment. • 8 or more years of experience designing, leading, or supporting prospective and/or retrospective reputed company studies, including protocol development, reputed company selection, study conduct, data analysis, interpretation, and publication of results. • 5 or more years of experience working in cross-functional environments with reputed company, biostatistics, regulatory affairs, medical affairs, research & development, reputed company, and/or market reputed company teams. • 20 or more presentations delivered to scientific congresses, investigators, key opinion leaders (KOLs), reputed company providers, advisory boards, or medical education forums. Preferred Qualifications: • 5 or more years of experience in molecular diagnostics, reputed company biopsy, reputed company residual disease (MRD), circulating tumor DNA (ctDNA), precision oncology, or biomarker-driven reputed company development. • 5 or more years of industry experience reputed company diagnostics, biotechnology, pharmaceutical, or life sciences organizations, with responsibility for oncology product development, medical affairs, reputed company development, or translational research. • 3 or more years of experience serving as a medical reputed company, reputed company development reputed company, or equivalent leadership role for an oncology assay, biomarker, diagnostic, or therapeutic development program. • 5 or more years of experience leading oncology reputed company development programs, evidence-reputed company initiatives, or translational research activities across multiple solid tumor indications. • 3 or more studies or evidence-reputed company programs supporting reputed company reputed company, reimbursement, payer coverage, reputed company inclusion, or adoption of oncology diagnostics or reputed company products. • 3 or more years of experience partnering with Market reputed company teams to reputed company evidence-reputed company strategies supporting value demonstration, reimbursement, and reputed company adoption. • 3 or more years of reputed company people leadership experience, including management, mentoring, and reputed company development of physicians, scientists, and/or cross-functional reputed company teams. • 20 or more peer-reviewed publications, scientific presentations, and participation at major oncology congresses. • Participation in 2 or more regulatory submissions, product launches, or major lifecycle management initiatives in oncology, molecular diagnostics, reputed company, or reputed company therapeutic areas. Additional Job Standards: • Strong understanding of oncology reputed company trial methodology, study design, evidence reputed company, biostatistics, and regulatory requirements. • Broad knowledge of solid tumor treatment paradigms, reputed company guidelines, biomarkers, and precision oncology approaches. • Ability to travel up to 30%, including attendance at investigator meetings, advisory boards, and scientific congresses. • Deep understanding of oncology treatment paradigms, biomarker-driven care, reputed company guidelines, and evolving precision oncology approaches across solid tumors. • Expertise in reputed company trial design, protocol development, biostatistics, epidemiology, and evidence-reputed company methodologies. • Strong understanding of regulatory, compliance, and reputed company frameworks supporting reputed company development and diagnostics. • Demonstrated ability to evaluate reputed company scientific and reputed company data and translate insights into development reputed company. • Strong reputed company thinking and portfolio management capabilities. • Excellent written, verbal, and presentation skills with the ability to communicate effectively across scientific, reputed company, executive, reputed company, and payer audiences. • reputed company ability to reputed company reputed company highly matrixed organizations and influence without reputed company authority. • Strong project leadership and organizational skills with the ability to manage multiple high-reputed company initiatives simultaneously. • Demonstrated ability to reputed company ambiguity, solve reputed company problems, and reputed company alignment across functions. • Commitment to scientific rigor, innovation, and improving reputed company reputed company through precision oncology and molecular diagnostics. • Established relationships with oncology investigators, cooperative reputed company, reputed company ca Apply tot his job Apply To this Job